Main Article Content
Abstract
Objective – to study the features of iron metabolism and the pathogenetic mechanisms of anemia development in rheumatoid arthritis.
Methods. The studies were conducted in 121 women with anemia in rheumatoid arthritis. The control group consisted of 79 practically healthy women. The study included an assessment of peripheral blood parameters, iron metabolism parameters (serum iron, total iron binding capacity, latent iron binding capacity, transferrin saturation coefficient), acute phase inflammatory proteins (CRP, α1-acid glycoprotein, neopterin). The assessment of iron reserves was carried out by the level of serum ferritin, which was studied by the enzyme immunoassay using test systems. The content of hepcidin-25 was determined by the enzyme immunoassay using test systems. The concentration of cytokines (IL-6, TNF-α, IFN-γ) was determined on a Lazurite enzyme immunoassay analyzer.
Results.The revealed anemia in RA patients was hypochromic, microcytic with reduced serum iron levels against a background of high ferritin content. In the study of hepcidin, its high level was determined, correlating with the level of pro-inflammatory cytokines (IL6, TNF-α, IFN-γ).
Conclusions. Induced by pro-inflammatory cytokines, hepcidin promotes increased iron sequestration in macrophages, disrupting iron export from cells by blocking the activity of the ferroportin protein. The modulation of the biological activity of hepcidin, which is a key factor in the regulation of iron homeostasis, causes the formation of anemic syndrome in RA. Anemia in RA occurs as a result of functional iron deficiency, as opposed to true iron deficiency in iron deficiency anemia.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Pulatov U., Kobilov U. Anemia in patients with rheumatic arthritis, features, causes, treatment. Eurasian Journal of Academic Research. 2024; 4(10): 43-50. Russian (Пулатов У.С., Кобилов У.А. Анемия у больных с ревматическим артритом, особенности, причины, лечение //Евразийский журнал академических исследований. 2024. Т. 4, № 10. С. 43-50.) doi: 10.5281/zenodo.13907486
Vatutin NG, Smirnova AS, Kalinkina NV, Shevelek AN. Anemia in patients with rheumatoid arthritis: features of pathogenesis, diagnosis and treatment. Russian Medical Journal. 2013. 21(21): 1069-1062. Russian (Ватутин Н.Г., Смирнова А.С., Калинкина Н.В., Шевелек А.Н. Анемия у больных ревматоидным артритом: особенности патогенеза, диагностики и лечения //Русский медицинский журнал. 2013. Т. 21, № 21. С. 1069-1062)
Greenshane YuI, Shabalin VV, Kusaev VV. Anemic syndrome in rheumatoid arthritis: Diagnostic approaches and treatment opportunities. Therapeutic Archive. 2016; 88(5): 107-112. Russian (Гриншейн Ю.И., Шабалин В.В., Кусаев В.В. Анемический синдром при ревматоидном артрите: подход к диагностике и возможности терапии //Терапевтический архив. 2016. Т. 88, № 5. С. 107-112.) doi: 10.17116/terarkh2016885107-112
Sakhin VP, Kryukov EV, Grigoriev MA, Kazakov EP, Sotnikov AV, Gordienko AV, Rukavitsin OA. Iron metabolism, cytokine secretion in patients with rheumatologic pathology. Clinical Medicine. 2020; 98(9-10): 691-698. (Сахин В.П., Крюков Е.В., Григорьев М.А., Казаков Е.П., Сотников А.В., Гордиенко А.В., Рукавицин О.А. Значение обмена железа, цитокинов в патогенезе анемии у больных ревматологического профиля //Клиническая медицина. 2020. Т. 98, № 9-10. С. 691-698.) doi: 10.30629/0023-2149-2020-98-9-10-691-698
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O. A new mouse liver-specific gene, encoding a protein homologous to humam antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001; 276(11) :7811-7819. doi: 10.1074/jbc.M008923200
Nemet E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hupoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113(9): 1271-1276. doi: 10.1172/JCI20945